In Vitro Antiherpesviral Activity of 5-Alkyl Derivatives of 1-β-d-Arabinofuranosyluracil

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial Agents and Chemotherapy Vol. 16; no. 2; pp. 158 - 163
Main Authors Machida, H, Sakata, S, Kuninaka, A, Yoshino, H, Nakayama, C, Saneyoshi, M
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.08.1979
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
AbstractList Several 5-alkyl derivatives of 1-β- d -arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action on cell growth in human embryonic lung fibroblasts. 1-β- d -Arabinofuranosylcytosine, 9-β- d -arabinofuranosyladenine, and 5-iododeoxyuridine (IUdR) were included as reference materials. Among the 5-alkyl derivatives of araU, arabinosylthymine was the most active, followed by 5-ethyl- and 5-propyl-araU. 5-Ethyl-araU was as active as IUdR and more active than 9-β- d -arabinofuranosyladenine against herpes simplex virus (HSV) type 1 and did not inhibit cell growth at a concentration as high as 1,000 μg/ml. 5-Butyl- and 5-methoxymethyl-araU, as well as araU, exhibited relatively low activity. The araU derivatives tested were as active against HSV WT-34, an isolate from a patient with keratitis, as against HSV type 1. Against an IUdR-resistant isolate, HSV WT-20, arabinosylthymine was less inhibitory than IUdR. Deoxyribonucleic acid synthesis in HSV type 1-infected cells was markedly inhibited by arabinosylthymine, IUdR, and 5-ethyl-araU, whereas cellular deoxyribonucleic acid synthesis in uninfected cells was significantly inhibited by IUdR but not by arabinosylthymine or 5-ethyl-araU.
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
Several 5-alkyl derivatives of 1-β-d-arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action on cell growth in human embryonic lung fibroblasts. 1-β-d-Arabinofuranosylcytosine, 9-β-d-arabinofuranosyladenine, and 5-iododeoxyuridine (IUdR) were included as reference materials. Among the 5-alkyl derivatives of araU, arabinosylthymine was the most active, followed by 5-ethyl- and 5-propyl-araU. 5-Ethyl-araU was as active as IUdR and more active than 9-β-d-arabinofuranosyladenine against herpes simplex virus (HSV) type 1 and did not inhibit cell growth at a concentration as high as 1,000 μg/ml. 5-Butyl- and 5-methoxymethyl-araU, as well as araU, exhibited relatively low activity. The araU derivatives tested were as active against HSV WT-34, an isolate from a patient with keratitis, as against HSV type 1. Against an IUdR-resistant isolate, HSV WT-20, arabinosylthymine was less inhibitory than IUdR. Deoxyribonucleic acid synthesis in HSV type 1-infected cells was markedly inhibited by arabinosylthymine, IUdR, and 5-ethyl-araU, whereas cellular deoxyribonucleic acid synthesis in uninfected cells was significantly inhibited by IUdR but not by arabinosylthymine or 5-ethyl-araU.
Several 5-alkyl derivatives of 1-beta-d-arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action on cell growth in human embryonic lung fibroblasts. 1-beta-d-Arabinofuranosylcytosine, 9-beta-d-arabinofuranosyladenine, and 5-iododeoxyuridine (IUdR) were included as reference materials. Among the 5-alkyl derivatives of araU, arabinosylthymine was the most active, followed by 5-ethyl- and 5-propyl-araU. 5-Ethyl-araU was as active as IUdR and more active than 9-beta-d-arabinofuranosyladenine against herpes simplex virus (HSV) type 1 and did not inhibit cell growth at a concentration as high as 1,000 mug/ml. 5-Butyl- and 5-methoxymethyl-araU, as well as araU, exhibited relatively low activity. The araU derivatives tested were as active against HSV WT-34, an isolate from a patient with keratitis, as against HSV type 1. Against an IUdR-resistant isolate, HSV WT-20, arabinosylthymine was less inhibitory than IUdR. Deoxyribonucleic acid synthesis in HSV type 1-infected cells was markedly inhibited by arabinosylthymine, IUdR, and 5-ethyl-araU, whereas cellular deoxyribonucleic acid synthesis in uninfected cells was significantly inhibited by IUdR but not by arabinosylthymine or 5-ethyl-araU.
Author Chikao Nakayama
Mineo Saneyoshi
Akira Kuninaka
Haruhiko Machida
Hiroshi Yoshino
Shinji Sakata
AuthorAffiliation 1 Research Laboratory, Yamasa Shoyu Company Limited, Choshi 288
2 Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060, Japan
AuthorAffiliation_xml – name: 2 Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060, Japan
– name: 1 Research Laboratory, Yamasa Shoyu Company Limited, Choshi 288
Author_xml – sequence: 1
  givenname: H
  surname: Machida
  fullname: Machida, H
– sequence: 2
  givenname: S
  surname: Sakata
  fullname: Sakata, S
– sequence: 3
  givenname: A
  surname: Kuninaka
  fullname: Kuninaka, A
– sequence: 4
  givenname: H
  surname: Yoshino
  fullname: Yoshino, H
– sequence: 5
  givenname: C
  surname: Nakayama
  fullname: Nakayama, C
– sequence: 6
  givenname: M
  surname: Saneyoshi
  fullname: Saneyoshi, M
BackLink https://www.ncbi.nlm.nih.gov/pubmed/485126$$D View this record in MEDLINE/PubMed
BookMark eNp1ULtOwzAUtRCvFtgYGbIi4WLHteMMDFF5VarEUiExWY5rU0NqV3Za1N_iQ_gmXAXxGJiu7j0PnXv6YNd5pwE4xWiAcc4vq2o0wGyQDzDlO6CHUckhoyXbBT2EGINDjoaHoB_jC0o7LdEB2B9yinPWA09jlz3aNviscq2d67DUcW2DbLJKtXZt203mTUZh1bxumuxaB7uW6a7j9ozhxzucwSrI2jpvVkE6HzdNmso2x2DPyCbqk695BKa3N9PRPZw83I1H1QRKQjGHpM71jCBVEjw0lJlCE1RoXFCiTW2QKmpSKKwoJwhRzRChCBc1NbRGvOSEHIGrzna5qhd6prRrU3qxDHYhw0Z4acVfxNm5ePZrQWjO8VZ_0elV8DEGbb6lGIltvSLVKzATuUj1Jvp5R5dxkYsXvwouPfcf9-x3tG_jrvsEZx08t8_zNxu0SJ5CSvXj8AnbIZAk
CitedBy_id crossref_primary_10_1080_07328318208078828
crossref_primary_10_3987_COM_06_10869
crossref_primary_10_1016_0166_3542_82_90044_4
crossref_primary_10_1007_BF01880663
crossref_primary_10_1016_j_carres_2011_07_026
crossref_primary_10_1016_0163_7258_80_90034_0
crossref_primary_10_1007_BF01145807
crossref_primary_10_1016_0166_3542_87_90084_2
crossref_primary_10_1016_0166_1280_94_80140_1
crossref_primary_10_1016_j_bmc_2007_06_058
crossref_primary_10_1016_j_tet_2008_08_014
crossref_primary_10_1002_prac_19843260618
crossref_primary_10_1016_0166_3542_84_90030_5
crossref_primary_10_3987_COM_06_S_K_50
crossref_primary_10_1016_0166_3542_83_90024_4
crossref_primary_10_3987_COM_08_S_N_50
ContentType Journal Article
Copyright Copyright © 1979, American Society for Microbiology
Copyright_xml – notice: Copyright © 1979, American Society for Microbiology
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOI 10.1128/AAC.16.2.158
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList


CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
Biology
Chemistry
EISSN 1098-6596
EndPage 163
ExternalDocumentID 10_1128_AAC_16_2_158
10.1128/AAC.16.2.158
485126
aac_16_2_158
Genre Journal Article
GroupedDBID ---
.55
.GJ
0R~
23M
2WC
39C
3O-
4.4
53G
5GY
5RE
5VS
6J9
ACGFO
ADBBV
AENEX
AGNAY
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CGR
CS3
CUY
CVF
DIK
E3Z
EBS
ECM
EIF
EJD
F5P
FRP
GX1
H13
HH5
HYE
HZ~
H~9
J5H
K-O
KQ8
L7B
LSO
MVM
NEJ
NPM
O9-
OK1
P2P
RHF
RHI
RNS
RPM
RSF
TR2
UHB
VH1
W2D
W8F
WH7
WHG
WOQ
X7M
X7N
XOL
Y6R
ZGI
ZXP
~A~
-
08R
0R
55
A
AAPBV
ABFLS
ADACO
ADBIT
AFMIJ
BXI
GJ
HZ
ZA5
AAYXX
CITATION
5PM
ID FETCH-LOGICAL-a3518-3b2ed30c9314f56f7e307e1753efbf0c7b37c1c583005e6035017b5f5b089833
IEDL.DBID RPM
ISSN 0066-4804
IngestDate Tue Sep 17 21:23:24 EDT 2024
Thu Sep 12 17:51:43 EDT 2024
Tue Dec 28 13:59:02 EST 2021
Sat Sep 28 08:42:42 EDT 2024
Wed May 18 15:29:03 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a3518-3b2ed30c9314f56f7e307e1753efbf0c7b37c1c583005e6035017b5f5b089833
OpenAccessLink https://aac.asm.org/content/aac/16/2/158.full.pdf
PMID 485126
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_352813
highwire_asm_aac_16_2_158
crossref_primary_10_1128_AAC_16_2_158
pubmed_primary_485126
asm2_journals_10_1128_AAC_16_2_158
PublicationCentury 1900
PublicationDate 19790801
PublicationDateYYYYMMDD 1979-08-01
PublicationDate_xml – month: 8
  year: 1979
  text: 19790801
  day: 1
PublicationDecade 1970
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Antimicrobial Agents and Chemotherapy
PublicationTitleAlternate Antimicrob Agents Chemother
PublicationYear 1979
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
SSID ssj0006590
Score 1.3200088
Snippet Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
Several 5-alkyl derivatives of 1-beta-d-arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action on cell growth in human...
Several 5-alkyl derivatives of 1-β-d-arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action on cell growth in human...
Several 5-alkyl derivatives of 1-β- d -arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action on cell growth in human...
SourceID pubmedcentral
crossref
asm2
pubmed
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 158
SubjectTerms Arabinofuranosyluracil
Arabinofuranosyluracil - analogs & derivatives
Arabinofuranosyluracil - pharmacology
Biosynthesis
Biosynthesis; Chemistry; Mechanisms of Action and Resistance
Cell Division - drug effects
Chemistry
Cytopathogenic Effect, Viral - drug effects
DNA - biosynthesis
Herpes Simplex
Herpes Simplex - drug therapy
Mechanisms of Action and Resistance
Thymidine - metabolism
Uridine
Uridine - analogs & derivatives
Title In Vitro Antiherpesviral Activity of 5-Alkyl Derivatives of 1-β-d-Arabinofuranosyluracil
URI http://aac.asm.org/content/16/2/158.abstract
https://www.ncbi.nlm.nih.gov/pubmed/485126
https://journals.asm.org/doi/10.1128/AAC.16.2.158
https://pubmed.ncbi.nlm.nih.gov/PMC352813
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Bb9MwGLVYBWgXBGWIsjFZCHaa0ziOHecYdZsGUlEPBY1TZDu2FtEmVdMh9W_th_CbZsfJ1h64cI0dJ8r77GfHz-8D4LOleJclLkWUFG6b0VCUcqdxj7Aw2JhQtucrpt_Z9Y_42w296Q6FNZ2sslKyDKrFMqjK21ZbuVqqca8TG8-mE-dIgsn4ABzY-OxX6N3oy6j_r2KpFMU8jHuxe8THWTYJMAuiAFN-CJ7HdrLhPBUGollG-7TUWwXv0NK-ZHKHg65eg1fd5BFm_iXfgGe6GoIXPp3kdgheTruN8iE4m3lL6u05nD-dsGrO4RmcPZlVb9-CX18r-LPcrGuYVZvSVl3pxul-7VOUTywBawMpyha_twt4YeP1T2sV3rjLGP29RwXK1sKur2tzZ3mvbpzQXahycQTmV5fzyTXq0i0gQSjmiMhIFyRUKcGxocwk2vZ_7Zw8tZEmVIkkicKKcudwr1m7JZlIaqgMecoJeQcGVV3p9wAywwoHNuNaxElSSMvEYWHs2KAKmQo1Ap_cN8-77tLk7Uok4rlFKMcsj3KL0Ah86RHJV9554x_1Rj1cuW01F0LtlB152B5b8KCPANuD87HYmW3vl9gYbE23fcx9-N8bj8EhTpPUSwdPwGCzvtMf7XRmI08dmdDTNoofAOrw84c
link.rule.ids 230,315,730,783,787,888,27938,27939,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLagXLYXLt0Q5Woh2NOcxknsJI9RYepgnfrQofFkxY4torVJ1aSTys_ih_CbsONka5F4gNccx0l0zvFnx5-_A8B7DfGmSlyMiJ-ZbUZFUBwZjruHU4WVcnlzvmJyTscXwedLctkeCqtaWmUheO4U84VT5N8bbuVyIYYdT2w4nYyMIgn2h3fBPZ2uLu3W6O34S4n9s6LBFAWRG3R0dy8aJsnIwdTxHEyifXA_0NMNo6rQS6uFtwtMnVjwFjDtkia3UOjkMbjo3t-ST66cdc0d8eMPacd__cAn4FE7LYWJtT4Fd2TRBw9socpNHzyctFvwfXA0tWLXm2M4uz27VR3DIzi9lcHeHIBvpwX8mterEiZFneumS1kZRrF-irAlK2CpIEHJ_Gozhx91Jlw3IuSVuYzRr58oQ8kq1Sv3Uq01opaVodCnIp8fgtnJp9lojNpCDij1CY6Qzz2Z-a6IfRwoQlUo9cgijUaoVFy5IuR-KLAgkdHOl7TZ7Aw5UYS7URz5_jPQK8pCPgeQKpqZMKKRTIMwzLjGeDdTetQRGY9TMQDvjC9Zm4gVa9Y4XsS05xmmzGPa8wPwofM0W1pNj7-0G3RhwHSvLE3Flu3QhsNNDzaYBoDuhMmN2ch471q08xs5b-vsF_9741uwN55NztjZ6fmXl2Afx2FsCYqvQK9ereVrPWmq-ZsmR34DPf8UbQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFL0aBaa98FGG6PiKEOxpTuIkTpzHqKPagE59KGh7smInFtHapGpSpO5n8UP4Tdhxs7VIvOw1dhxZ914fO_f4XICPCuJ1lbgYET_TaUZJUEw1x93DqcRSury9XzG-CM--B18uyeUe0O4uTEvaF7ywy9ncLoufLbdyMRdOxxNzJuOhViTBvrPIpPMAHqqQdWl3Tt-swSExf1cUoKKAukFHefeokyRDG4e2Z2NCD-BRoLYcWlmhl9ZzbxecOsHgLXDaJU5uIdHoKVx1czAElGt71XBb3Pwj73ifST6DJ5vtqZWYHs9hLy_78NgUrFz3YX-8ScX34XhiRK_XJ9b07g5XfWIdW5M7Oez1C7g6L60fRbOsrKRsCtV1kdeaWay-IkzpCquSFkHJ7Ho9s05VRPxqxchr_RijP79RhpJlqk7wlVwpZK1qTaVPRTE7hOno83R4hjYFHVDqE0yRz708810R-ziQJJRRrlaYXGuF5pJLV0TcjwQWhGoN_Txsk54RJ5Jwl8bU919Cr6zK_BVYoQwz7U4hzdMgijKusN7NpFp9RMbjVAzgg7Yn2wRkzdqzjkeZsj7DIfOYsv4APnXWZguj7fGffoPOFZgalaWp2Go7NC5xO4JxqAGEO65y26zlvHdblAO0st7G4Ef3ffE97E9OR-zb-cXX13CA4yg2PMU30GuWq_yt2js1_F0bJn8B7y8W7Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Vitro+Antiherpesviral+Activity+of+5-Alkyl+Derivatives+of+1-%CE%B2-d-Arabinofuranosyluracil&rft.jtitle=Antimicrobial+agents+and+chemotherapy&rft.au=Machida%2C+Haruhiko&rft.au=Sakata%2C+Shinji&rft.au=Kuninaka%2C+Akira&rft.au=Yoshino%2C+Hiroshi&rft.date=1979-08-01&rft.issn=0066-4804&rft.eissn=1098-6596&rft.volume=16&rft.issue=2&rft.spage=158&rft.epage=163&rft_id=info:doi/10.1128%2FAAC.16.2.158&rft.externalDocID=10.1128%2FAAC.16.2.158
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0066-4804&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0066-4804&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0066-4804&client=summon